search
Back to results

ISSUE3: International Study on Syncope of Uncertain Etiology 3

Primary Purpose

Syncope

Status
Completed
Phase
Phase 4
Locations
Italy
Study Type
Interventional
Intervention
Dual chamber pacemeker
Sponsored by
Medtronic Bakken Research Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Syncope focused on measuring syncope, implantable loop recorder

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Suspected or certain neurally-mediated syncope, based on the Guidelines recently published by the Task Force on Syncope of the European Society of Cardiology 2,3 (Appendix 1); More than 3 syncope episodes in the last 2 years; Clinical presentation of syncope of sufficient severity requiring treatment initiation in the physician's and patient's judgement. Age > 40 years. Negative carotid sinus massage. Patients accept to have an ILR implantation. Exclusion criteria: Carotid sinus hypersensitivity Suspected or certain heart disease and high likelihood of cardiac syncope: Symptomatic orthostatic hypotension diagnosed by standing blood pressure measurement; Loss of consciousness different from syncope (e.g. epilepsy, psychiatric, metabolic, drop-attack, TIA, intoxication, cataplexy); Subclavian steal syndrome; Psychologically or physically (due to any other illness) or cognitively unfit for participation in the study according to the opinion of the investigator; Patient compliance doubtful; Patient geographically or otherwise inaccessible for follow-up; Patient unwilling or unable to give informed consent; Life expectancy <1 year.

Sites / Locations

  • Medtronic Italia S.p.A.

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

Dual chamber pacemaker

Dual chamber pacemeker

Arm Description

Dual chamber pacemaker programmed ODO (switched OFF)

Medtronic dual chamber pacemaker programmed ON and with Rate Drope Response programmed ON

Outcomes

Primary Outcome Measures

Syncope Recurrence Rate
Intention to treat analysis of percentage of patients with syncope recurrence at 2 years follow-up after study arm assignement

Secondary Outcome Measures

Full Information

First Posted
July 31, 2006
Last Updated
September 28, 2015
Sponsor
Medtronic Bakken Research Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00359203
Brief Title
ISSUE3: International Study on Syncope of Uncertain Etiology 3
Official Title
ISSUE3: International Study on Syncope of Uncertain Etiology 3 Pacemaker Therapy for Patients With Asystolic Neurally-mediated Syncope
Study Type
Interventional

2. Study Status

Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
September 2011 (Actual)
Study Completion Date
November 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medtronic Bakken Research Center

4. Oversight

5. Study Description

Brief Summary
ISSUE 3 is a multi-center, prospective, randomised controlled double-blind study aimed to assess the effectiveness of pacemaker therapy for prevention of asystolic neurally-mediated syncope.
Detailed Description
In asystolic neurally-mediated syncope (NMS) documented by Implantable Loop recorder (ILR), ISSUE-2, an observational trial, showed that pacemaker was effective in reducing the 1-year first syncope recurrence rate from 33% rate before implant (ILR phase 1) to 5% rate after implant (phase 2). Moreover, the control non-asystolic group still continued to have a 41% recurrence rate after the first recurrence of syncope, thus supporting the conclusion that the reduction with pacemaker was due to the beneficial effect of pacemaker itself and not to other factors. However a formal controlled trial is needed to confirm these findings.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Syncope
Keywords
syncope, implantable loop recorder

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
511 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dual chamber pacemaker
Arm Type
Placebo Comparator
Arm Description
Dual chamber pacemaker programmed ODO (switched OFF)
Arm Title
Dual chamber pacemeker
Arm Type
Active Comparator
Arm Description
Medtronic dual chamber pacemaker programmed ON and with Rate Drope Response programmed ON
Intervention Type
Device
Intervention Name(s)
Dual chamber pacemeker
Other Intervention Name(s)
Any model of Medtronic pacemakers with Rate Drop Respons algorhythm:, K700, K900, Enpulse, Advisa, Versa
Primary Outcome Measure Information:
Title
Syncope Recurrence Rate
Description
Intention to treat analysis of percentage of patients with syncope recurrence at 2 years follow-up after study arm assignement
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Suspected or certain neurally-mediated syncope, based on the Guidelines recently published by the Task Force on Syncope of the European Society of Cardiology 2,3 (Appendix 1); More than 3 syncope episodes in the last 2 years; Clinical presentation of syncope of sufficient severity requiring treatment initiation in the physician's and patient's judgement. Age > 40 years. Negative carotid sinus massage. Patients accept to have an ILR implantation. Exclusion criteria: Carotid sinus hypersensitivity Suspected or certain heart disease and high likelihood of cardiac syncope: Symptomatic orthostatic hypotension diagnosed by standing blood pressure measurement; Loss of consciousness different from syncope (e.g. epilepsy, psychiatric, metabolic, drop-attack, TIA, intoxication, cataplexy); Subclavian steal syndrome; Psychologically or physically (due to any other illness) or cognitively unfit for participation in the study according to the opinion of the investigator; Patient compliance doubtful; Patient geographically or otherwise inaccessible for follow-up; Patient unwilling or unable to give informed consent; Life expectancy <1 year.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michele Brignole, MD
Organizational Affiliation
Ospedali del Tigullio, Lavagna
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medtronic Italia S.p.A.
City
Rome
ZIP/Postal Code
00165
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
22565936
Citation
Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, Wieling W, Beiras X, Deharo JC, Russo V, Tomaino M, Sutton R; International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012 May 29;125(21):2566-71. doi: 10.1161/CIRCULATIONAHA.111.082313. Epub 2012 May 7.
Results Reference
derived
Links:
URL
http://www.ncbi.nlm.nih.gov/pubmed/22565936
Description
ISSUE3 main results publication PubMed

Learn more about this trial

ISSUE3: International Study on Syncope of Uncertain Etiology 3

We'll reach out to this number within 24 hrs